Life Science Outsourcing, Inc., a leading contract manufacturer and value-added service provider to medical device and life science companies, announced today that it has acquired J-Pac Medical, a manufacturing, packaging and sterilization outsourcing partner to medical device and diagnostic companies.
Cadence, Inc., a leading contract manufacturer of medical and drug delivery devices and specialty commercial products, announced today that it has acquired Utitec, Inc., a manufacturer specializing in miniature, deep drawn medical device and commercial components. Utitec is headquartered in Watertown, Conn., with an additional medical facility located in Alajuela, Costa Rica.
Pharmaceutical Engineering® magazine is proud to announce the 2021 Roger F. Sherwood Article of the Year is “Medical Device UDI Components Management in the European Union”
Collected from qualified healthy donors that meet baseline FDA 21 CFR 1271 requirements, industry’s first In Stock GMP-compliant Cryopreserved Leukopaks significantly decrease lead time
SaniSure, a global developer and manufacturer of single-use technology for the biopharmaceutical industry, announced today it has acquired GL Engineering (GLE) of East Hanover, New Jersey.
Cytiva’s FlexFactory is a one-stop solution for equipment and services following single-use technology and a modular design tailored to the manufacturer’s needs.
AllCells, the industry leader in the procurement and customization of human-derived hematological tissues and services, is pleased to announce the expansion of its flagship processing facility in Alameda, California.
Amcor Unveils State-of-the-art Healthcare Packaging Facility In Singapore To Serve Accelerating Customer Demands In Asia Pacific
Sartorius will expand its capacities for production, innovation, and storage at its French facilities in Aubagne, Cergy and Lourdes in order to meet the strong demand of the biopharmaceutical industry
The Global Pathogen Center for Pathogen Research and Human Health to broaden understanding of emerging pathogens – ranging from Zika virus to SARS-CoV-2 (which causes COVID-19) – and to expedite critically needed treatments and vaccines.
Vaxess Technologies celebrates the grand opening of their 3,600 square feet pilot GMP manufacturing facility on Monday.
Watson-Marlow is pleased to announce that construction will start in October 2021, on a new state-of-the-art manufacturing facility in the United States, with first production due in late 2022.